Revolution Medicines, Inc. (RVMD)
$208.63-$12.52 (-5.66%) Today
Mark A. Goldsmith - OfficerMark A. Goldsmith - OfficerRevolution Medicines Inc is a clinical-stage precision oncology company developing novel targeted therapies for RAS-addicted cancers. The Company possesses structure-based drug discovery capabilities built upon chemical biology and cancer pharmacology know-how and proprietary technologies that enable the creation of small molecules tailored to unconventional binding sites. Its research and development pipeline comprises inhibitors that bind directly to RAS variants (RAS(ON) Inhibitors), designed to be used as monotherapy, in combination with other RAS(ON) Inhibitors and/or other therapeutic agents.
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 52 | 295,738 | $54.46M |
| Grant or award | 14 | 30,226 | |
| Option exercise | 24 | 518,470 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
87 Form 4 filings on record, the earliest from Oct 3, 2024, newest first. Filing history page 1 of 3.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jeff Cislini - Officer | Option exercise | Common Stock | 29,680 | $18.56 | $551K | |
| Jeff Cislini - Officer | Option exercise | Common Stock | 26,600 | $21.61 | $575K | |
| Jeff Cislini - Officer | Open-market sale | Common Stock | 3,400 | $207.24 | $705K | |
| Jeff Cislini - Officer | Open-market sale | Common Stock | 17,323 | $208.37 | $3.61M | |
| Jeff Cislini - Officer | Open-market sale | Common Stock | 25,817 | $209.25 | $5.40M | |
| Jeff Cislini - Officer | Open-market sale | Common Stock | 2,540 | $210.26 | $534K | |
| Jeff Cislini - Officer | Open-market sale | Common Stock | 4,500 | $211.34 | $951K | |
| Jeff Cislini - Officer | Open-market sale | Common Stock | 3,314 | $212.06 | $703K | |
| Jeff Cislini - Officer | Option exercise | Stock Option (Right to Buy) | 29,680 | $0.00 | - | |
| Jeff Cislini - Officer | Option exercise | Stock Option (Right to Buy) | 26,600 | $0.00 | - | |
| Mark A. Goldsmith - Officer | Option exercise | Common Stock | 80,000 | $4.73 | $378K | |
| Mark A. Goldsmith - Officer | Open-market sale | Common Stock | 5,128 | $207.23 | $1.06M | |
| Mark A. Goldsmith - Officer | Open-market sale | Common Stock | 24,917 | $208.37 | $5.19M | |
| Mark A. Goldsmith - Officer | Open-market sale | Common Stock | 35,938 | $209.26 | $7.52M | |
| Mark A. Goldsmith - Officer | Open-market sale | Common Stock | 3,813 | $210.25 | $802K | |
| Mark A. Goldsmith - Officer | Open-market sale | Common Stock | 6,583 | $211.33 | $1.39M | |
| Mark A. Goldsmith - Officer | Open-market sale | Common Stock | 3,621 | $212.08 | $768K | |
| Mark A. Goldsmith - Officer | Open-market sale | Common Stock | 190 | $207.25 | $39K | |
| Mark A. Goldsmith - Officer | Open-market sale | Common Stock | 951 | $208.36 | $198K | |
| Mark A. Goldsmith - Officer | Open-market sale | Common Stock | 1,351 | $209.28 | $283K | |
| Mark A. Goldsmith - Officer | Open-market sale | Common Stock | 136 | $210.40 | $29K | |
| Mark A. Goldsmith - Officer | Open-market sale | Common Stock | 245 | $211.47 | $52K | |
| Mark A. Goldsmith - Officer | Open-market sale | Common Stock | 127 | $212.06 | $27K | |
| Mark A. Goldsmith - Officer | Open-market sale | Common Stock | 177 | $207.25 | $37K | |
| Mark A. Goldsmith - Officer | Open-market sale | Common Stock | 937 | $208.36 | $195K | |
| Mark A. Goldsmith - Officer | Open-market sale | Common Stock | 1,405 | $209.27 | $294K | |
| Mark A. Goldsmith - Officer | Open-market sale | Common Stock | 126 | $210.40 | $27K | |
| Mark A. Goldsmith - Officer | Open-market sale | Common Stock | 229 | $211.46 | $48K | |
| Mark A. Goldsmith - Officer | Open-market sale | Common Stock | 126 | $212.06 | $27K | |
| Mark A. Goldsmith - Officer | Option exercise | Stock Option (Right to Buy) | 80,000 | $0.00 | - | |
| Sushil Patel | Open-market sale | Common Stock | 300 | $187.83 | $56K | |
| Sushil Patel | Open-market sale | Common Stock | 100 | $188.57 | $19K | |
| Sushil Patel | Open-market sale | Common Stock | 600 | $190.55 | $114K | |
| Sushil Patel | Open-market sale | Common Stock | 541 | $191.87 | $104K | |
| Sushil Patel | Open-market sale | Common Stock | 881 | $192.61 | $170K | |
| Sushil Patel | Option exercise | Stock Option (Right to Buy) | 2,955 | $0.00 | - | |
| Sushil Patel | Option exercise | Common Stock | 2,955 | $37.54 | $111K | |
| Sushil Patel | Open-market sale | Common Stock | 300 | $183.17 | $55K | |
| Sushil Patel | Open-market sale | Common Stock | 900 | $184.59 | $166K | |
| Sushil Patel | Open-market sale | Common Stock | 1,100 | $185.90 | $204K | |
| Sushil Patel | Open-market sale | Common Stock | 858 | $186.92 | $160K | |
| Jack Anders - Officer | Open-market sale | Common Stock | 5,651 | $169.24 | $956K | |
| Jack Anders - Officer | Open-market sale | Common Stock | 300 | $170.32 | $51K | |
| Jack Anders - Officer | Option exercise | Common Stock | 20,000 | $18.56 | $371K | |
| Jack Anders - Officer | Open-market sale | Common Stock | 4,553 | $167.35 | $762K | |
| Jack Anders - Officer | Open-market sale | Common Stock | 9,496 | $168.20 | $1.60M | |
| Jack Anders - Officer | Option exercise | Stock Option (Right to Buy) | 20,000 | $0.00 | - | |
 Lorence H. Kim | Grant or award | Stock Option (Right to Buy) | 3,127 | $0.00 | - | |
| Lorence H. Kim | Grant or award | Common Stock | 1,191 | $0.00 | - | |
| Alexis Borisy | Grant or award | Stock Option (Right to Buy) | 3,127 | $0.00 | - | |
| Alexis Borisy | Grant or award | Common Stock | 1,191 | $0.00 | - | |
| Elizabeth M. Anderson | Grant or award | Stock Option (Right to Buy) | 3,127 | $0.00 | - | |
| Elizabeth M. Anderson | Grant or award | Common Stock | 1,191 | $0.00 | - | |
| Sandra Horning | Grant or award | Stock Option (Right to Buy) | 3,127 | $0.00 | - | |
| Sandra Horning | Grant or award | Common Stock | 1,191 | $0.00 | - | |
| Frank Clyburn | Grant or award | Common Stock | 1,191 | $0.00 | - | |
| Frank Clyburn | Grant or award | Stock Option (Right to Buy) | 3,127 | $0.00 | - | |
| Sushil Patel | Grant or award | Stock Option (Right to Buy) | 3,127 | $0.00 | - | |
| Sushil Patel | Grant or award | Common Stock | 1,191 | $0.00 | - | |
| Flavia Borellini | Grant or award | Common Stock | 1,191 | $0.00 | - | |
| Flavia Borellini | Grant or award | Stock Option (Right to Buy) | 3,127 | $0.00 | - | |
 Anthony Mancini - Officer | Open-market sale | Common Stock | 4,615 | $156.12 | $720K | |
| Mark A. Goldsmith - Officer | Open-market sale | Common Stock | 10,020 | $156.12 | $1.56M | |
| Jeff Cislini - Officer | Open-market sale | Common Stock | 2,157 | $156.12 | $337K | |
| Jack Anders - Officer | Open-market sale | Common Stock | 2,722 | $156.12 | $425K | |
| Stephen Michael Kelsey - Officer | Open-market sale | Common Stock | 4,175 | $156.12 | $652K | |
 Margaret A. Horn - Officer | Option exercise | Common Stock | 3,302 | $29.80 | $98K | |
| Margaret A. Horn - Officer | Option exercise | Common Stock | 25,725 | $26.50 | $682K | |
| Margaret A. Horn - Officer | Open-market sale | Common Stock | 29,600 | $160.12 | $4.74M | |
| Margaret A. Horn - Officer | Option exercise | Stock Option (Right to Buy) | 15,546 | $0.00 | - | |
| Margaret A. Horn - Officer | Option exercise | Stock Option (Right to Buy) | 44,854 | $0.00 | - | |
| Margaret A. Horn - Officer | Option exercise | Stock Option (Right to Buy) | 573 | $0.00 | - | |
| Margaret A. Horn - Officer | Option exercise | Stock Option (Right to Buy) | 3,302 | $0.00 | - | |
| Margaret A. Horn - Officer | Option exercise | Stock Option (Right to Buy) | 25,725 | $0.00 | - | |
| Margaret A. Horn - Officer | Option exercise | Common Stock | 15,546 | $40.74 | $633K | |
| Margaret A. Horn - Officer | Option exercise | Common Stock | 44,854 | $29.80 | $1.34M | |
| Margaret A. Horn - Officer | Open-market sale | Common Stock | 60,400 | $160.17 | $9.67M | |
| Margaret A. Horn - Officer | Open-market sale | Common Stock | 3,575 | $156.12 | $558K | |
| Margaret A. Horn - Officer | Option exercise | Common Stock | 573 | $40.74 | $23K | |
| Margaret A. Horn - Officer | Option exercise | Common Stock | 8,906 | $40.74 | $363K | |
| Margaret A. Horn - Officer | Open-market sale | Common Stock | 1,315 | $144.28 | $190K | |
| Margaret A. Horn - Officer | Open-market sale | Common Stock | 885 | $145.15 | $128K | |
| Margaret A. Horn - Officer | Open-market sale | Common Stock | 700 | $146.04 | $102K | |
| Margaret A. Horn - Officer | Open-market sale | Common Stock | 500 | $147.27 | $74K | |
| Margaret A. Horn - Officer | Open-market sale | Common Stock | 1,800 | $148.72 | $268K | |
| Margaret A. Horn - Officer | Open-market sale | Common Stock | 4,600 | $149.64 | $688K | |
| Margaret A. Horn - Officer | Open-market sale | Common Stock | 200 | $150.17 | $30K | |
| Margaret A. Horn - Officer | Option exercise | Stock Option (Right to Buy) | 1,094 | $0.00 | - | |
| Margaret A. Horn - Officer | Option exercise | Stock Option (Right to Buy) | 8,906 | $0.00 | - | |
| Margaret A. Horn - Officer | Option exercise | Common Stock | 1,094 | $42.45 | $46K | |
| Anthony Mancini - Officer | Option exercise | Common Stock | 3,121 | $33.62 | $105K | |
| Anthony Mancini - Officer | Open-market sale | Common Stock | 700 | $153.30 | $107K | |
| Anthony Mancini - Officer | Open-market sale | Common Stock | 2,000 | $154.06 | $308K | |
| Anthony Mancini - Officer | Open-market sale | Common Stock | 421 | $154.82 | $65K | |
| Anthony Mancini - Officer | Option exercise | Stock Option (Right to Buy) | 3,121 | $0.00 | - | |
| Anthony Mancini - Officer | Option exercise | Common Stock | 3,120 | $33.62 | $105K | |
| Anthony Mancini - Officer | Open-market sale | Common Stock | 1,671 | $131.66 | $220K | |
| Anthony Mancini - Officer | Open-market sale | Common Stock | 1,049 | $132.88 | $139K | |
| Anthony Mancini - Officer | Open-market sale | Common Stock | 400 | $134.34 | $54K | |
| Anthony Mancini - Officer | Option exercise | Stock Option (Right to Buy) | 3,120 | $0.00 | - | |
| Mark A. Goldsmith - Officer | Option exercise | Common Stock | 23,244 | $4.09 | $95K | |
| Mark A. Goldsmith - Officer | Option exercise | Common Stock | 96,756 | $4.73 | $458K | |
| Mark A. Goldsmith - Officer | Open-market sale | Common Stock | 120,000 | $150.09 | $18.01M | |
| Mark A. Goldsmith - Officer | Option exercise | Stock Option (Right to Buy) | 23,244 | $0.00 | - | |
| Mark A. Goldsmith - Officer | Option exercise | Stock Option (Right to Buy) | 96,756 | $0.00 | - | |
| Anthony Mancini - Officer | Option exercise | Common Stock | 37,450 | $33.62 | $1.26M | |
| Anthony Mancini - Officer | Open-market sale | Common Stock | 1,800 | $93.22 | $168K | |
| Anthony Mancini - Officer | Open-market sale | Common Stock | 3,128 | $94.16 | $295K | |
| Anthony Mancini - Officer | Open-market sale | Common Stock | 21,086 | $95.49 | $2.01M | |
| Anthony Mancini - Officer | Open-market sale | Common Stock | 11,036 | $96.43 | $1.06M | |
| Anthony Mancini - Officer | Open-market sale | Common Stock | 400 | $97.21 | $39K | |
| Anthony Mancini - Officer | Option exercise | Stock Option (Right to Buy) | 37,450 | $0.00 | - | |
| Lin Wei - Officer | Open-market sale | Common Stock | 2,073 | $99.48 | $206K | |
| Stephen Michael Kelsey - Officer | Open-market sale | Common Stock | 4,302 | $99.48 | $428K | |
| Mark A. Goldsmith - Officer | Open-market sale | Common Stock | 12,871 | $99.48 | $1.28M | |
| Margaret A. Horn - Officer | Open-market sale | Common Stock | 4,583 | $99.48 | $456K | |
| Jack Anders - Officer | Open-market sale | Common Stock | 2,753 | $99.48 | $274K | |
| Jeff Cislini - Officer | Open-market sale | Common Stock | 1,795 | $99.48 | $179K | |
| Jeff Cislini - Officer | Open-market sale | Common Stock | 1,163 | $97.44 | $113K | |
 Xiaolin Wang - Officer | Open-market sale | Common Stock | 2,010 | $99.48 | $200K | |
| Elizabeth M. Anderson | Gift | Common Stock | 15,000 | $0.00 | - | |
| Elizabeth M. Anderson | Gift | Common Stock | 15,000 | $0.00 | - |
A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| MARK A GOLDSMITH | Director, Officer | 80,000 | $16.94M | View on EDGAR | |
| JEFFREY TODD CISLINI | Officer | 75,894 | $16.07M | View on EDGAR | |
| THE JONATHAN GOLDSMITH REVOCABLE TRUST | Director, Officer | 3,000 | $635K | View on EDGAR |
Revolution Medicines, Inc. (RVMD) had 18 insider filings in the last 90 days, with the most recent on 2026-08-25. The full record for RVMD runs to 87 Form 4 filings, the earliest from 2024-10-03. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
No insider purchases of RVMD were filed in the last 90 days. 2 purchases are on record for this company.
52 insider sales of RVMD were filed in the last 90 days, totaling $54.46M.
This page tracks RVMD Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add RVMD to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
